| 摘要 |
The invention relates to the treatment of cardiac dysfunction. In particular, certain compounds, believed to be glucagon-GLP-1 dual agonist compounds, exert a positive inotropic effect while preserving the energy balance of the heart, and so may be superior to known inotropic agents such as dobutamine, norepinephrine and glucagon. |
| 申请人 |
ZEALAND PHARMA A/S |
发明人 |
PETERSEN, JØRGEN SØBERG;KJOELBYE, ANNE LOUISE;SKOVGAARD, MARIE;PEDERSEN, HENRIK DUELUND;AXELSEN, LENE;RIBER, DITTE;MEIER, EDDI;HANSEN, RIE SCHULTZ;FOSGERAU, KELD;LARSEN, BJARNE DUE |
